183 related articles for article (PubMed ID: 35679626)
1. Is 2045 the best we can do? Mitigating the HPV-related oropharyngeal cancer epidemic.
Schuman A; Anderson KS; Day AT; Ferrell J; Sturgis EM; Dahlstrom KR
Expert Rev Anticancer Ther; 2022 Jul; 22(7):751-761. PubMed ID: 35679626
[TBL] [Abstract][Full Text] [Related]
2. Considerations in Human Papillomavirus-Associated Oropharyngeal Cancer Screening: A Review.
Day AT; Fakhry C; Tiro JA; Dahlstrom KR; Sturgis EM
JAMA Otolaryngol Head Neck Surg; 2020 Jul; 146(7):656-664. PubMed ID: 32379293
[TBL] [Abstract][Full Text] [Related]
3. Projected Association of Human Papillomavirus Vaccination With Oropharynx Cancer Incidence in the US, 2020-2045.
Zhang Y; Fakhry C; D'Souza G
JAMA Oncol; 2021 Oct; 7(10):e212907. PubMed ID: 34473210
[TBL] [Abstract][Full Text] [Related]
4. Awareness of Human Papillomavirus (HPV) and HPV Vaccination amongst the General Population in Germany: Lack of Awareness and Need for Action.
Sharma SJ; Schartinger VH; Wuerdemann N; Langer C; Möllenhoff K; Collin L; Sutton L; Riedl D; Kreuter A; Lechner M; Wieland U; Klussmann JP
Oncol Res Treat; 2022; 45(10):561-567. PubMed ID: 35850111
[TBL] [Abstract][Full Text] [Related]
5. Lack of knowledge regarding HPV and its relation to oropharyngeal cancer among medical students.
Sallam M; Dababseh D; Yaseen A; Al-Haidar A; Ettarras H; Jaafreh D; Hasan H; Al-Salahat K; Al-Fraihat E; Hassona Y; Şahin GÖ; Mahafzah A
Cancer Rep (Hoboken); 2022 Jul; 5(7):e1517. PubMed ID: 34291614
[TBL] [Abstract][Full Text] [Related]
6. The potential impact of prophylactic human papillomavirus vaccination on oropharyngeal cancer.
Guo T; Eisele DW; Fakhry C
Cancer; 2016 Aug; 122(15):2313-23. PubMed ID: 27152637
[TBL] [Abstract][Full Text] [Related]
7. The impact of HPV vaccination on the prevention of oropharyngeal cancer: A scoping review.
Kaczmarczyk KH; Yusuf H
Community Dent Health; 2022 Mar; 39(1):14-21. PubMed ID: 34304398
[TBL] [Abstract][Full Text] [Related]
8. Screening Awareness of HPV-Related Oropharyngeal Cancers and Attitudes and Concerns towards HPV Vaccination Among Parents : HPV and Oropharyngeal Cancer.
Dundar Y; Eldem I; Schwartz C; Pomeroy L; Cordero J; Arslan O; Levent F
J Cancer Educ; 2022 Aug; 37(4):1152-1160. PubMed ID: 33411252
[TBL] [Abstract][Full Text] [Related]
9. Prevention and Screening of HPV Malignancies.
Dahlstrom KR; Day AT; Sturgis EM
Semin Radiat Oncol; 2021 Oct; 31(4):297-308. PubMed ID: 34455985
[TBL] [Abstract][Full Text] [Related]
10. Knowledge of Human Papillomavirus (HPV) and Oropharyngeal Cancer and Acceptability of the HPV Vaccine among Dental Students.
Farsi NJ; Al Sharif S; Al Qathmi M; Merdad M; Marzouki H; Merdad L
Asian Pac J Cancer Prev; 2020 Dec; 21(12):3595-3603. PubMed ID: 33369457
[TBL] [Abstract][Full Text] [Related]
11. Discussing HPV and oropharyngeal cancer in dental settings: gender and provider-type matter.
Daley EM; Thompson EL; Beckstead J; Driscoll A; Vamos C; Piepenbrink RP; Desch J; Merrell L; Richardson Cayama MB; Owens H; Lovett SM
Hum Vaccin Immunother; 2021 Dec; 17(12):5454-5459. PubMed ID: 34890526
[TBL] [Abstract][Full Text] [Related]
12. Increasing HPV vaccination coverage to prevent oropharyngeal cancer: A cost-effectiveness analysis.
Choi SE; Choudhary A; Huang J; Sonis S; Giuliano AR; Villa A
Tumour Virus Res; 2022 Jun; 13():200234. PubMed ID: 34974194
[TBL] [Abstract][Full Text] [Related]
13. Correlates of human papillomavirus vaccination intent for oropharyngeal cancer prevention among gay and bisexual men living in the United States.
Stull C; Bennis SL; Rosser BRS; Wilkerson JM; Zoschke IN; Jiang Z; Nyitray AG; Khariwala SS; Ross MW
J Am Dent Assoc; 2024 Jan; 155(1):26-38.e1. PubMed ID: 37988048
[TBL] [Abstract][Full Text] [Related]
14. A Multi-state Evaluation of Oral Health Students' Knowledge of Human Papillomavirus-Related Oropharyngeal Cancer and HPV Vaccination.
Rutkoski H; Tay DL; Dixon BL; Pinzon LM; Mooney R; Winkler JR; Kepka D
J Cancer Educ; 2020 Oct; 35(5):1017-1025. PubMed ID: 31222578
[TBL] [Abstract][Full Text] [Related]
15. Trends in Human Papillomavirus-Associated Cancers, Demographic Characteristics, and Vaccinations in the US, 2001-2017.
Liao CI; Francoeur AA; Kapp DS; Caesar MAP; Huh WK; Chan JK
JAMA Netw Open; 2022 Mar; 5(3):e222530. PubMed ID: 35294540
[TBL] [Abstract][Full Text] [Related]
16. Human papillomavirus: optimizing opportunities for prevention.
Browne S; Feemster KA
Curr Opin Pediatr; 2022 Apr; 34(2):132-139. PubMed ID: 35152231
[TBL] [Abstract][Full Text] [Related]
17. Could the human papillomavirus vaccination be cost-effective in males for the prevention of oropharyngeal cancer?
Isaranuwatchai W; Graham DM; Siu LL; Hoch JS
Expert Rev Pharmacoecon Outcomes Res; 2014 Dec; 14(6):763-5. PubMed ID: 25095728
[TBL] [Abstract][Full Text] [Related]
18. Human papillomavirus-related oropharyngeal cancer in the HIV-infected population.
Wang CC; Palefsky JM
Oral Dis; 2016 Apr; 22 Suppl 1():98-106. PubMed ID: 27109278
[TBL] [Abstract][Full Text] [Related]
19. HPV-related oropharyngeal cancer: a review on burden of the disease and opportunities for prevention and early detection.
Timbang MR; Sim MW; Bewley AF; Farwell DG; Mantravadi A; Moore MG
Hum Vaccin Immunother; 2019; 15(7-8):1920-1928. PubMed ID: 31050595
[TBL] [Abstract][Full Text] [Related]
20. Human papillomavirus in cervical cancer and oropharyngeal cancer: One cause, two diseases.
Berman TA; Schiller JT
Cancer; 2017 Jun; 123(12):2219-2229. PubMed ID: 28346680
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]